Plasma cells are a type of white blood cell that arise from B lymphocytes and play an essential role in the immune response by secreting immunoglobulins. In the case of plasma cell tumours, they are typically formed from clones of a single cell and exhibit characteristic secretion of paraproteins. Multiple myeloma (MM) is the most common plasma cell neoplasm, which commonly presents with disseminated bone marrow involvement. A solitary plasmacytoma is a localized tumour of plasma cells that can arise in bone or soft tissue. A plasmacytoma can represent the first manifestation of a generalized myeloma or remain an independent localized neoplasm. Extramedullary plasmacytomas (EMP) can arise in various areas in the body. Approximately 80% of EMP arise in the head and neck, but this still constitutes less than 1% of head and neck malignancies. Common locations include the nasal cavity, paranasal sinuses, and nasopharynx. EMP shows a male predilection of 3:1 and a peak incidence in the fifth and seventh decades. We present 6 cases of MM that involve various sites in the head and neck.
Case Presentation

Case 1
This is a 62-year-old man with a 4-year history of MM. The patient had a history of thoracic spine involvement that required surgical decompression. The patient subsequently developed multiple soft-tissue masses in the head and neck, and a tingling sensation in the cheek. Magnetic resonance and computed tomographic imaging ( Figure 1 ) revealed a mass in the right masticator space, with involvement of the pterygopalatine fossa. Infiltration of the thyroid ala was also present. Tissue sampling confirmed the presence of myeloma.
Case 2
A 44-year-old woman presented 5 years earlier with a myelomatous lesion in the C4 vertebra. The patient then developed multiple lesions in the head and neck, including the masticator space, with contiguous involvement of the maxillary sinus, orbit, and clivus ( Figure 2 ). The patient was treated with radiation therapy.
Case 3
This 52-year-old man presented with right-sided neck adenopathy. The clinical examination also revealed the presence of a mass at the base of the tongue. Computed tomographic imaging was performed to localize the extent of disease ( Figure 3, A-D) . Pathology revealed the presence of atypical plasma cells. Kappa staining showed homogeneous uniform positivity, which confirmed a monoclonal proliferation consistent with a diagnosis of MM ( Figure 3 , E and F).
Case 4
A 66-year-old man with a 4-year history of MM that initially presented as a T6 spinal lesion. The patient subsequently presented with a cough and dysphonia. Computed tomographic imaging revealed a subglottic mass (Figure 4 ). Histopathology confirmed a diagnosis of myeloma.
Case 5
An 87-year-old man with a 4-year history of MM subsequently presented with right eye pain, decreased visual acuity, and a sixth nerve palsy. Imaging revealed an infiltrative mass that involved the right cavernous sinus and sphenoid sinus ( Figure 5, A-D) .
Case 6
This is a 47-year-old man with a history of human immunodeficiency virus, and hepatitis A, B, and C. The patient developed a sensation of pressure in the left maxillary sinus and double vision. Imaging revealed a large mass in the left maxillary sinus with extension into the adjacent nasal cavity and retroantral region. A second focus of disease was also present in the left frontal sinus (Figure 6 , A-E). Pathologic assessment supported a diagnosis of MM ( Figure 6F ).
Discussion
MM is the most common plasma cell neoplasm. It accounts for 10% of hematologic malignancies and 1% of malignant diseases [1] . In 2010, an estimated 2300 new cases of MM were diagnosed in Canada [2] , which reflects an annual incidence rate of 5 cases per 100,000. Rarely presenting before the age of 40 years, MM is typically diagnosed in older populations, with a median age of 65 years [1] . Incidence rates of MM reflect a male predilection and are highest in African American populations [3] . Symptomatic MM presents clinically with disseminated involvement, serum monoclonal immunoglobulins (M protein), lytic bone lesions, anemia, renal impairment, and hypercalcemia. In some patients, the disease presents at an asymptomatic benign stage referred to as monoclonal gammopathy of undetermined significance or at an asymptomatic premalignant stage called smoldering MM. Both monoclonal gammopathy of undetermined significance and smoldering MM carry a high risk of progression to malignant disease. Progression of MM is dependent on changes in the bone marrow microenvironment, which produces factors that support proliferation and survival. In most cases, this confines the disease to the bone marrow; however, EMP can arise in various areas in the body. In one study of 1003 patients with MM, 7% of patients had extramedullary involvement at the time of diagnosis and 6% of patients developed soft-tissue EMP at 30-month follow-up. Approximately 80% of EMPs arise in the head and neck, but EMPs still constitute less than 1% of head and neck malignancies [4] . Common locations include the nasal cavity, paranasal sinuses, and nasopharynx.
It is theorized that novel therapeutic agents and treatment regimens combined with longer survival times in patients with MM in recent years have resulted in an increased occurrence of atypical extramedullary disease that was not seen in the past due to poor prognosis and limited treatment options. In one study [5] , an increase in extramedullary disease from 5% to 12% at relapse was observed in patients treated with high-dose therapy compared with those treated with conventional dose therapy. This is likely due to the selection of resistant clones after intensified therapy. In other reports, extramedullary disease has been associated with the use of thalidomide, which induces dedifferentiation and modification of surface adhesion molecules. This ultimately allows malignant cells to escape the bone marrow microenvironment and invade other tissues [6, 7] . Thus, as treatment continues to advance and MM becomes a progressively more chronic disease, extramedullary progression and relapse will become a more important consideration in the management of patients with MM.
Our pictorial essay presents 6 cases of atypical extramedullary recurrence of MM in the head and neck. These atypical presentations have increased in occurrence in recent years due to improved treatment regimens and longer survival times. On radiologic examination, it is important to recognize that MM can present in rather unusual locations in the head and neck, and can mimic more common entities such as squamous cell carcinoma and lymphoma both on imaging as well as on clinical examination. Imaging is vital in assessing disease location and extent (staging) as well as guiding locations for tissue sampling. The latter will be important in establishing the correct diagnosis and thus directing treatment.
